MedTrace Logo

Actual Use Trial of Atorvastatin Calcium 10 mg

NCT01964326 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1311

Last updated 2021-02-21

Study results available
· View outcomes & findings →

Summary

The purpose of this actual use study is to simulate the over the counter use of atorvastatin calcium 10 mg.

Conditions

Interventions

DRUG

Atorvastatin calcium 10 mg

Atorvastatin calcium 10 mg tablet to be administered orally every day

Sponsors & Collaborators

  • Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

    lead INDUSTRY

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01964326 on ClinicalTrials.gov